Anti-TNF Therapies Carry Varying Levels of TB Risk (CME/CE)

Courtesy MedPage Today Infectious Disease  Thu, 07/02/2009 - 07:59

LITTLE FALLS, N.J. (MedPage Today) -- The risk of tuberculosis is higher for patients receiving anti-tumor necrosis factor (anti-TNF) monoclonal antibody therapy than for those receiving soluble TNF receptor therapy for any indication, French researchers found.


 

More related items

HIV No Bar to Liver Transplant in Carcinoma (CME/CE)
(MedPage Today) -- Hepatocellular carcinoma patients who have HIV do just as well after a liver transplant as those who are not infected, French researchers reported.

SABCS: Delay Chemo to Aid Wound Healing (CME/CE)
SAN ANTONIO (MedPage Today) -- Therapy for metastatic breast cancer that includes bevacizumab (Avastin) should be delayed at least seven days after venous access lines are implanted to...

Anti-TNF Antibodies May Boost Herpes Zoster Risk
BERLIN (MedPage Today) -- Herpes zoster infection could arise from treatment of rheumatoid arthritis with a monoclonal antibody against tumor necrosis factor, investigators here concluded.

The Pregnancy Journal: A Day-to-Day Guide to a...
Since its publication in 1996, this definitive journal for expectant families has sold over a million copies. Author A. Christine Harris brings a revised and thoroughly updated edition to...

Country Save HE Laundry Detergent, Powder, 160-Load,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com